| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |